amensupport (@amensupport) 's Twitter Profile
amensupport

@amensupport

Our mission is to provide support to the families of and people with MEN Type 1, 2A and 2B

ID: 1017768080313847809

linkhttp://www.AMENSupport.org calendar_today13-07-2018 13:49:54

318 Tweet

114 Followers

212 Following

NET Research Foundation (@curenets) 's Twitter Profile Photo

NET Research Foundation awarded UCL Professor Martyn Caplin a 4-year Petersen Accelerator Award to study the molecular cause of mesenteric fibrosis in small intestinal NETs and develop new diagnostic and imaging tools to treat it. #NETcancer Royal Free London #neuroendocrinecancer Paul Conroy

<a href="/CureNETs/">NET Research Foundation</a> awarded <a href="/ucl/">UCL</a> Professor Martyn Caplin a 4-year Petersen Accelerator Award to study the molecular cause of mesenteric fibrosis in small intestinal NETs and develop new diagnostic and imaging tools to treat it.
#NETcancer <a href="/RoyalFreeNHS/">Royal Free London</a> #neuroendocrinecancer <a href="/uknets/">Paul Conroy</a>
Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

I just completed a death certificate and I did not falsify the cause Of the many baseless accusations levelled at physicians during the pandemic this is perhaps one of the most insulting: that we would testify inauthentically about a life we tried so hard to save #medtwitter

NANETS (@nanets1) 's Twitter Profile Photo

Looking for ways to expand your professional development on Twitter? Don't miss this webinar with Mark Lewis, MD, FASCO, moderated by Heloisa Soares MD! Designed for both Twitter novices and experts, you don't want to miss out on learning from the best! Register now: nanets.net/component/civi…

Looking for ways to expand your professional development on Twitter? Don't miss this webinar with <a href="/marklewismd/">Mark Lewis, MD, FASCO</a>, moderated by <a href="/helops79/">Heloisa Soares MD</a>!

Designed for both Twitter novices and experts, you don't want to miss out on learning from the best!

Register now: nanets.net/component/civi…
Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

Scan shows that my pancreas — what’s left of it! — looks stable and no cancer has spread to my liver 🙌🏻 Here’s to another year of enjoying my family and dedicating myself to the work that is my calling — I know I am a lucky patient Thank you #MedTwitter for all the support!

Middle Eastern NETs (@middleeastnets) 's Twitter Profile Photo

We are very excited and humbled about your interest in this unique Event. We look forward to seeing you on February 9, 2022 at 20:00

We are very excited and humbled about your interest in this unique Event.  We look forward to seeing you on February 9, 2022 at 20:00
Amy Lee Lightner, MD (@amylightnermd) 's Twitter Profile Photo

Man Undergoes First-In-World Full Multi-Transplant to Treat Rare Appendix Cancer…multiple disciplines together can offer a life saving option not offered anywhere else in the world ⁦Cleveland Clinic⁩ ⁦Miguel Regueiro⁩ ⁦⁦Scott R. Steele⁩ my.clevelandclinic.org/patient-storie…

JAMA Surgery (@jamasurgery) 's Twitter Profile Photo

#Parathyroidectomy provides improved and sustained quality of life in patients with primary #hyperparathyroidism. ja.ma/3xn22Rq #Research

Sharla McBride (@sharlamcbride) 's Twitter Profile Photo

If you do anything RIGHT NOW. Stop and say a prayer for Bills’ Demar Hamlin. They are giving him CPR on the field. This is absolutely horrific🙏🙏🙏🙏

If you do anything RIGHT NOW. Stop and say a prayer for Bills’ Demar Hamlin. They are giving him CPR on the field. This is absolutely horrific🙏🙏🙏🙏
🦆¯\_(ツ)_/¯ (@cantguarddurant) 's Twitter Profile Photo

ESPN The players reactions are no joke. This game should be canceled. This is one of the scariest moments in football history. Prayers up🙏

Thor Halfdanarson (@oncothor) 's Twitter Profile Photo

How should we follow non-operatively managed patients with nonfunctional pancreatic G1/G2 NETs...? I hope most/all of us have accepted that surveillance is an acceptable (preferred) approach for most patients. Here is an attempt to summarize follow-up. Would love to hear comments

How should we follow non-operatively managed patients with nonfunctional pancreatic G1/G2 NETs...? I hope most/all of us have accepted that surveillance is an acceptable (preferred) approach for most patients. Here is an attempt to summarize follow-up. Would love to hear comments